| 2025-04-30 |
详情>>
股本变动：
变动后总股本206.39万股
|
| 2025-04-01 |
详情>>
内部人交易：
Gozani Shai等共交易2笔
|
| 2025-03-31 |
详情>>
业绩披露：
2024年年报每股收益-3.96美元,归母净利润-780.61万美元,同比去年增长-19.55%
|
| 2025-02-14 |
股东大会：
将于2025-03-21召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal (the Merger Proposal) to adopt the Merger Agreement. A copy of the Merger Agreement is attached as Annex A to the accompanying proxy statement.
2.To consider and vote on a proposal (the Adjournment Proposal) to adjourn the Special Meeting, if necessary, and for a minimum period of time reasonable under the circumstances, to ensure that any necessary supplement or amendment to the proxy statement accompanying this notice is provided to Company stockholders a reasonable amount of time in advance of the Special Meeting, or to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal.
3.To consider and vote on a proposal (the Compensation Proposal), to approve, by non-binding, advisory vote, the compensation that will or may be paid or become payable to our named executive officers in connection with the consummation of the Merger.
|
| 2024-12-18 |
复牌提示：
2024-12-17 16:00:10 停牌，复牌日期 2024-12-17 16:35:00
|
| 2024-11-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.1美元,归母净利润-602.57万美元,同比去年增长-23.48%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-2.37美元,归母净利润-451.75万美元,同比去年增长-45.2%
|
| 2024-08-06 |
财报披露：
美东时间 2024-08-06 盘前发布财报
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-1.67美元,归母净利润-302.96万美元,同比去年增长-92.45%
|
| 2024-03-27 |
股东大会：
将于2024-04-30召开股东大会
会议内容 ▼▲
- 1.To elect two directors, each to serve a three-year term expiring in 2027;
2.To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2024-03-01 |
详情>>
业绩披露：
2023年年报每股收益-6.27美元,归母净利润-652.95万美元,同比去年增长-47.84%
|
| 2023-11-22 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2023-10-26 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.61美元,归母净利润-487.99万美元,同比去年增长-31.01%
|
| 2023-09-11 |
股东大会：
将于2023-10-19召开股东大会
会议内容 ▼▲
- 1.To approve a proposed amendment to the NeuroMetrix, Inc. Amended and Restated Certificate of Incorporation, as amended, in substantially the form attached to the proxy statement as Appendix A, to, at the discretion of the Board of Directors, effect a reverse stock split of our issued and outstanding shares of common stock, at a ratio of between 1:2 and 1:8, inclusive;
2.To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1.
|
| 2023-07-27 |
详情>>
业绩披露：
2023年中报每股收益-0.4美元,归母净利润-311.12万美元,同比去年增长-46.86%
|
| 2023-05-03 |
详情>>
业绩披露：
2023年一季报每股收益-0.2美元,归母净利润-157.42万美元,同比去年增长-64.22%
|
| 2023-03-30 |
股东大会：
将于2023-05-02召开股东大会
会议内容 ▼▲
- 1.To elect one director to serve a three-year term expiring in 2026;
2.To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement;
3.To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
4.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2023-03-22 |
详情>>
业绩披露：
2022年年报每股收益-0.62美元,归母净利润-441.66万美元,同比去年增长-93.59%
|
| 2022-10-20 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.53美元,归母净利润-372.47万美元,同比去年增长-191.35%
|
| 2022-03-24 |
股东大会：
将于2022-05-03召开股东大会
会议内容 ▼▲
- 1.to elect the persons nominated by the Board of Directors as Class III directors to serve until our 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal;
2.to approve the Corporation’s 2022 Equity Incentive Plan, which will replace the Corporation’s Twelfth Amended and Restated 2004 Stock Option and Incentive Plan, and which increases the number of shares of the Corporation’s common stock authorized for issuance under the plan by 300,000 shares;
3.to ratify the selection of Baker Tilly US, LLP as the Corporation’s independent auditors for fiscal 2022;
4.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-16 |
股东大会：
将于2021-04-27召开股东大会
会议内容 ▼▲
- 1.to elect the persons nominated by the Board of Directors as Class II directors to serve until our 2024 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal;
2.to approve the Corporation’s Twelfth Amended and Restated 2004 Stock Option and Incentive Plan, which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 500,000 shares;
3.to approve the Corporation’s Fifth Amended and Restated 2010 Employee Stock Purchase Plan, which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 150,000 shares and raises the plan’s annual increase to the lesser of 50,000 shares or 1% of the Corporation’s outstanding shares of common stock;
4.to ratify the selection of Moody, Famiglietti & Andronico, LLP as the Corporation’s independent auditors for fiscal 2021;
5.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2020-03-16 |
股东大会：
将于2020-04-28召开股东大会
会议内容 ▼▲
- 1.to ratify the selection of Moody, Famiglietti & Andronico, LLP as the Corporation’s independent auditors for fiscal 2020;
2.to consider an advisory vote on compensation of our named executive officers;
3.to consider an advisory vote on the frequency of holding an advisory vote on compensation of our named executive officers;
4.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2019-11-19 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2019-10-18 |
股东大会：
将于2019-11-12召开股东大会
会议内容 ▼▲
- 1.To approve a proposed amendment to the NeuroMetrix, Inc. Amended and Restated Certificate of Incorporation, as amended, to effect (a) a reverse stock split of our issued and outstanding shares of common stock, at a ratio of between 1:4 and 1:10, and (b) a reduction in the number of authorized shares of the Company’s common stock from 100,000,000 to 25,000,000;
2.To approve the Company’s Eleventh Amended and Restated 2004 Stock Option and Incentive Plan which increases the number of shares of the Company’s common stock authorized for issuance thereunder by 3,270,000 shares (subject to adjustment if Proposal 1 is adopted and implemented);
3.To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1.
|
| 2019-03-13 |
股东大会：
将于2019-04-30召开股东大会
会议内容 ▼▲
- 1.to elect the persons nominated by the Board of Directors as Class III directors to serve until our 2022 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal;
2.to ratify the selection of Moody, Famiglietti & Andronico, LLP as the Corporation’s independent auditors for fiscal 2019;
3.to consider an advisory vote on compensation of our named executive officers;
4.to consider an advisory vote on the frequency of holding an advisory vote on compensation of our named executive officers;
5.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2018-03-09 |
股东大会：
将于2018-05-01召开股东大会
会议内容 ▼▲
- 1.to elect the persons nominated by the Board of Directors as Class II directors to serve until our 2021 annual meeting of stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal;
2.to approve the Corporation’s Tenth Amended and Restated 2004 Stock Option and Incentive Plan, which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 400,000 shares;
3.to approve the Corporation’s Fourth Amended and Restated 2010 Employee Stock Purchase Plan, which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 150,000 shares;
4.to ratify the selection of Moody, Famiglietti & Andronico, LLP as the Corporation’s independent auditors for fiscal 2018;
5.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2017-08-07 |
股东大会：
将于2017-09-15召开股东大会
会议内容 ▼▲
- 1. To approve the second tranche of the issuance of shares of our Series F convertible preferred stock to an institutional investor and its affiliates (the “Investor”) pursuant to the Securities Purchase Agreement, dated as of July 10, 2017, by and between the Corporation and the Investor (the “Securities Purchase Agreement”) and to approve the other transactions contemplated thereby;
2. To approve the resetting of the conversion prices of the Series D and Series E convertible preferred stock held by the Investor;
3. To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1 and 2;
4. To transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2017-05-11 |
详情>>
拆分方案：
每8.0000合并分成1.0000股
|
| 2017-03-29 |
股东大会：
将于2017-05-02召开股东大会
会议内容 ▼▲
- 1.to elect the one person nominated by the Board of Directors as a Class I director to serve until our 2020 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal;
2.to approve an amendment to our Third Amended and Restated Certificate of Incorporation, as amended, and authorize our Board of Directors, if in their judgment it is necessary, to effect a reverse stock split of our common stock, $0.0001 par value per share, at a ratio in the range of 1:2 to 1:8, such ratio to be determined in the discretion of our Board of Directors;
3.to approve the Corporation’s Ninth Amended and Restated 2004 Stock Option and Incentive Plan, which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 600,000 shares;
4.to authorize an adjournment of the annual meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 2;
5.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2017-01-23 |
股东大会：
将于2017-02-28召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of shares of our Series E convertible preferred stock and warrants to purchase shares of our common stock to an institutional investor and its affiliates (the “Investor”) pursuant to the Securities Purchase Agreement, dated as of December 28, 2016, by and between the Corporation and the Investor (the “Securities Purchase Agreement”) and to approve the other transactions contemplated thereby, including the resetting of the exercise prices of warrants to purchase shares of our common stock, to comply with NASDAQ Marketplace Rule 5635(d);
2.To approve the resetting of the conversion price of the Series D convertible preferred stock held by the Investor, as required by the Securities Purchase Agreement;
3.To approve an amendment to the Corporation’s Third Amended and Restated Certificate of Incorporation to increase the number of shares of our common stock authorized for issuance from 100,000,000 shares to 150,000,000 shares;
4.To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1, 2 and 3;
5.To transact such other business as may be properly brought before the Special Meeting and any adjournments thereof.
|
| 2016-03-17 |
股东大会：
将于2016-05-03召开股东大会
会议内容 ▼▲
- 1.to elect the two persons nominated by the Board of Directors as Class III directors, each to serve until our 2019 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal;
2.to approve the Corporation’s Eighth Amended and Restated 2004 Stock Option and Incentive Plan which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 500,000 shares;
3.to approve the Corporation’s Third Amended and Restated 2010 Employee Stock Purchase Plan which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 100,000 shares, subject to further adjustment annually as provided therein;
4.to ratify the selection of PricewaterhouseCoopers LLP to serve as our independent registered public accounting firm for the year ending December 31, 2016;
5.to approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement;
6.to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2015-12-01 |
详情>>
拆分方案：
每4.0000合并分成1.0000股
|
| 2015-09-29 |
股东大会：
将于2015-10-30召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our third amended and restated certificate of incorporation, as amended, to increase from 50,000,000 shares to 100,000,000 shares the aggregate number of shares of common stock, $0.0001 par value per share, that we are authorized to issue;
2.To approve an amendment to our third amended and restated certificate of incorporation, as amended, and authorize our Board of Directors, if in their judgment it is necessary, to effect a reverse stock split of our common stock, at a ratio in the range of 1:2 to 1:4, such ratio to be determined in the discretion of our Board of Directors;
3.To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1 or Proposal 2;
4.To transact such other business as may be properly brought before the Special Meeting or any adjournments or postponements thereof.
|
| 2015-03-30 |
股东大会：
将于2015-05-05召开股东大会
会议内容 ▼▲
- 1. to elect the two persons nominated by the Board of Directors as Class II directors, each to serve until our 2018 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal;
2. to approve the Corporation’s Seventh Amended and Restated 2004 Stock Option and Incentive Plan which increases the number of shares of the Corporation’s common stock authorized for issuance thereunder by 850,000 shares;
3. to ratify the selection of PricewaterhouseCoopers LLP to serve as our independent registered public accounting firm for the year ending December 31, 2015;
4. to transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|